Fingerprint
Dive into the research topics where Moshe Huberman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 20 Article
-
High prevalence of malignant melanoma in Israeli patients with Parkinson's disease
Inzelberg, R., Rabey, J. M., Melamed, E., Djaldetti, R., Reches, A., Badarny, S., Hassin-Baer, S., Cohen, O., Trau, H., Aharon-Peretz, J., Milo, R., Schwartz, M., Huberman, M., Gilead, L., Barchana, M., Liphshiz, I., Fitzer-Attas, C. & Giladi, N., Aug 2011, In: Journal of Neural Transmission. 118, 8, p. 1199-1207 9 p.Research output: Contribution to journal › Article › peer-review
32 Scopus citations -
Integration of motor imagery and physical practice in group treatment applied to subjects with Parkinson's disease
Tamir, R., Dickstein, R. & Huberman, M., Mar 2007, In: Neurorehabilitation and Neural Repair. 21, 1, p. 68-75 8 p.Research output: Contribution to journal › Article › peer-review
172 Scopus citations -
Electrogastrography in patients with Parkinson's disease
Naftali, T., Gadoth, N., Huberman, M. & Novis, B., Feb 2005, In: Canadian Journal of Neurological Sciences. 32, 1, p. 82-86 5 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Motor and non-motor sequence learning in patients with basal ganglia lesions: The case of serial reaction time (SRT)
Vakil, E., Kahan, S., Huberman, M. & Osimani, A., Jan 2000, In: Neuropsychologia. 38, 1, p. 1-10 10 p.Research output: Contribution to journal › Article › peer-review
111 Scopus citations -
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa
Rabey, J. M., Sagi, I., Huberman, M., Melamed, E., Korczyn, A., Giladi, N., Inzelberg, R., Djaldetti, R., Klein, C. & Berecz, G., 2000, In: Clinical Neuropharmacology. 23, 6, p. 324-330 7 p.Research output: Contribution to journal › Article › peer-review
179 Scopus citations